The aim of the study was to determine the expression of key genes involved in the PI3K/AKT signaling pathway, including PIK3CA, PTEN, AKT1, FOXO1, and FRAP, in patients with CRC. This evidence concerns the gene PTEN and colorectal carcinoma.